Solara Active Pharma Sciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹349.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.31 per cent from ₹313.54 crore. This corresponds to a year-on-year *(YoY) growth of 16.21 per cent.
Operating Profit
Operating Profit stands at ₹30.59 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.92 per cent from ₹34.73 crore. This corresponds to a year-on-year *(YoY) decline of 46.97 per cent.
PBDT
PBDT stands at ₹8.14 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.43 per cent from ₹14.39 crore. This corresponds to a year-on-year *(YoY) decline of 75.05 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-17.43 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 72.57 per cent from ₹-10.10 crore. This corresponds to a year-on-year *(YoY) decline of 315.45 per cent.
Net Profit
Net Profit stands at ₹-17.43 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 72.57 per cent from ₹-10.10 crore. This represents a 315.45 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Solara Active Pharma Sciences Ltd News
Solara Active Pharma Sciences Ltd Earnings
- YOY
- QOQ
Solara Active Pharma Sciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Solara Active Pharma Sciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Solara Active Pharma Sciences Ltd Financial Reports
Solara Active Pharma Sciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Solara Active | -2.80% | -1.40% | 6.06% | -5.28% | -17.89% | -4.78% |
| Indoco Remedies | -2.61% | -2.36% | 13.03% | -5.11% | -24.52% | -9.97% |
| Windlas Biotech | -5.77% | -3.73% | 8.20% | 9.47% | -10.16% | -15.45% |
| Kwality Pharma | 0.02% | 2.16% | 16.73% | 61.43% | 87.89% | 126.37% |
| Amrutanjan Healt | -0.19% | 5.78% | 11.15% | -2.78% | -20.32% | -12.50% |
| Shukra Pharma. | -0.50% | -9.46% | -4.42% | -26.08% | -23.06% | 83.51% |
| NGL Fine Chem | -2.81% | -3.91% | -0.30% | 45.59% | 47.65% | 97.56% |
Company Info
Company Information
Chairman (Non-Executive) : Deepak Vaidya
Managing Director : Jitesh Devendra
Executive Director (Fin) & CFO : Hariharan Subramaniam
Independent Director : Nirmal P Bhogilal
Independent Director : RAJAGOPALAN RAMAKRISHNAN
Independent Director : Kausalya Santhanam
Company Secretary : S Murali Krishna
Addtnl Independent Director : Ronald Tjeerd De Vries